Michael Chambers - Jun 2, 2022 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Michael Andrew Chambers
Stock symbol
SRPT
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/6/2022, 08:22 PM
Next filing
Aug 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +4.91K $0.00 4.91K Jun 2, 2022 Direct F1
holding SRPT Common Stock 75.2K Jun 2, 2022 By Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Award $0 +8.33K $0.00 8.33K Jun 2, 2022 Common Stock 8.33K $72.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning June 2, 2023.
F2 The option vests in three equal annual installments beginning June 2, 2023.